Renalytix announced a collaboration with Steno Diabetes Center Copenhagen to advance translation of precision medicine solutions for patients with diabetes and chronic kidney disease. The initial focus of the collaboration will be on developing a road map for implementation of #KidneyIntelX at the Center and affiliated practices. #Renalytix #StenoDiabetesCenter #BioUtah #UtahLifeSciences https://ow.ly/RUPj50SCMOC
BioUtah
Public Policy Offices
Salt Lake City, Utah 2,510 followers
Leading Utah's Life Sciences Industry
About us
BioUtah, the state’s independent life science association, was created to elevate the stature and influence of Utah’s life science community on the national and global stage. Launched in 2012, the organization serves Utah’s medical device, biopharma and healthcare industries through networking, advocacy and education programs. BioUtah creates value for its members through events, legislative initiatives and communication outreach. We foster collaboration within and between industry, government and education to provide growth opportunities through funding, talent acquisition/development and strategic partnerships.
- Website
-
http://bioutah.org/
External link for BioUtah
- Industry
- Public Policy Offices
- Company size
- 2-10 employees
- Headquarters
- Salt Lake City, Utah
- Type
- Nonprofit
- Founded
- 2012
- Specialties
- Access to BioUtah’s extensive network of key influencers on the state, national and global levels, Significant discounts on products and services, and Compelling educational and networking opportunities
Locations
-
Primary
2500 South State Street
Suite D224
Salt Lake City, Utah 84115, US
Employees at BioUtah
Updates
-
Michelle Mendoza, PhD, researcher at Huntsman Cancer Institute and associate professor of oncological sciences at the University of Utah and Jeffrey Weiss, PhD, professor of biomedical engineering and faculty member in the Scientific Computing and Imaging Institute at the University of Utah, are the recipients of a $2.6 million grant from the National Institutes of Health to research how tension in lung tissue affects the growth and distribution of tumors. This innovative approach could uncover new mechanisms for understanding how lung cancer develops. #HuntsmanCancerInstitute #UofU #NIH #UtahLifeSciences https://ow.ly/i29v50SENMP
-
-
Happy Pioneer Day from BioUtah! As we celebrate our state's heritage and progress this Pioneer Day, let's applaud the pioneers in life sciences who have shaped Utah into a hub of innovation and excellence. From the establishment of the first hospital in the Intermountain West in 1872, to landmark achievements like the first artificial heart transplant in a human in 1982, and to groundbreaking research institutions and visionary leaders in health care technologies, the Beehive State continues to lead the way. 🎆 #UtahPioneerDay #UtahLifeSciences #BioUtah Photos: 1. Nurses weigh a baby in the newborn wing of St. Mark’s, circa 1874. (St. Mark's Hospital via AP) 2. Artificial heart recipient Barney Clark smiles at his surgeon, Dr. William DeVries, at University of Utah Hospital the day after the historic implantation. (Associated Press)
-
-
Looking for a new workspace? The Mill at SLCC has available workspace for entrepreneurs who need a stable location to grow. This space is ideal for solo entrepreneurs who need to get out of the home office. Learn more at the link below. #UtahLifeSciences #SLCC https://lnkd.in/eTn6u93B
-
-
Did you know? The National Institutes of Health's America’s Seed Fund/Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program offers small business entrepreneurs in life sciences over $1.3 billion in non-dilutive funding for small business research and development. NIH SEED is hosting a webinar on Wednesday, July 31, to cover funding opportunities, resources for how to apply and policy updates. A live Q&A session will follow the presentation. Learn more and register: https://ow.ly/Wtmc50SERpx #NIHSEED #BioUtah #UtahLifeSciences #FundingOpportunities
-
-
Nominations for the 2024 BioUtah Life Sciences Awards are OPEN! Each year, as part of the Utah Life Sciences Summit, BioUtah awards individuals and/or companies that have made a significant impact in advancing the industry in Utah. Last year's winners include Dr. Dan Simmons of Intronex, Andrea Mazzocchi, PhD and Katie-Rose Skelly of Known Medicine, Mark Paul of Stryker, Civica Rx/Dan Liljenquist, and Rep. Jefferson Moss. Who do you want to see recognized this year? Learn more and submit your nominations today by clicking the link. Deadline ends August 23, 2024. #UtahLifeSciences #BioUtah #ULSS24 https://lnkd.in/gykv7WTF
-
-
The National Science Foundation (NSF) has released new funding opportunities for its SBIR/STTR program. Awards have increased to $305,000 for Phase I and $1,250,000 for Phase II. There is also a Fast-Track pilot opportunity. To learn more, please visit https://lnkd.in/gXA7wnw8 or contact The Utah Governor's Office of Economic Opportunity's #UtahInnovationCenter Important Dates: • #NASAIgnite: Closes July 30, 2024, at 3:00 PM MT • Army Release 17 & 19: Closes July 30, 2024, at 10:00 AM MT • Navy Open Topics: In pre-release; proposals accepted beginning Aug. 1, 2024 • Army Release 18: In pre-release; proposals accepted beginning Aug. 13, 2024 • USDA: Closes Sept. 17, 2024, at 3:00 PM MT. • #NSF: Proposals due Sept. 18, 2024, at 5:00 PM MT #SBIRfunding #STTRfunding https://lnkd.in/g9vj7YYy
-
-
The Economic Development Corporation of Utah (EDCUtah) will be joining the Salt Lake Chamber organization to drive Utah's business community forward. After careful consideration, the boards of both organizations have agreed to move forward with a framework and process for #EDCUtah to join the “family of teams” within the Chamber. #SaltLakeChamber https://ow.ly/4JnR50SCMvU
-
-
Owlet Baby Care announced CFO Kate Scolnick, will depart the company to pursue other opportunities, and re-affirmed 2024 financial goals. Amanda Twede Crawford, Owlet’s VP for financial planning and analysis, will assume the role of CFO. Kate will remain at the company in an advisory role for a transition period through September 2024. Learn more at the link below. #Owlet #BioUtah #UtahLifeSciences https://ow.ly/PlTA50SCMmg
-
-
Thermo Fisher Scientific has completed its acquisition of Olink Proteomics Holding AB, a leading provider of next-generation proteomics solutions. The transaction values #Olink at approximately $3.1 billion, net of $96 million of acquired cash. Olink Proteomics will become part of Thermo Fisher's Life Sciences Solutions segment. #ThermoFisher #BioUtah #UtahLifeSciences https://ow.ly/CrF550SCM8k
-